"In April 2015, we received notice that our Abbreviated New Drug Submission ("ANDS") for Quetiapine fumarate extended release tablets (a generic of Seroquel XR®) was accepted for review by Health Canada. This submission consists of 5 strengths, similar to our previous ANDA filing with the FDA."